Skip to content
Screener

Jade Biosciences JBIO Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$0.57Miss by $0.05
EPS estimate-$0.52

Next report

Aug 12, 2026 (In 2 days)
EPS estimate-$0.66

Financials

Q1 2026

Income statement

See full
Operating income-$43.4M-85.8%
Net income-$40.4M-5.8%
EPS (diluted)-$0.57+95.3%

Balance sheet

See full
Cash & equivalents$55.1M+24.6%
Total debt$808.0K+159%
Total equity$296.5M+455%
Total assets$319.4M+312%

Cash flow

See full
Operating cash flow-$24.1M-28.4%

Valuation & ratios

Valuation

as of 08/07/26
See full
Market cap$1.35B+436%
Enterprise value$1.3B+3,925%

Returns & leverage

See full
Debt / equity0×—
Current ratio14.3×-17.7×

FAQ

When did Jade Biosciences report Q1 2026 earnings?
Jade Biosciences (JBIO) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Jade Biosciences's Q1 2026 revenue and EPS?
Jade Biosciences reported eps of $-0.57 for Q1 2026.
Did Jade Biosciences beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.52 by $0.05.
How did Jade Biosciences's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 533.3% from $-0.09.
Where can I find Jade Biosciences's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-211973) and the 10-Q periodic report (0001193125-26-212088) directly on SEC EDGAR. The filing index links above go to sec.gov.